Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by A. Arenga
Pcn215 - Emerging Trends in the Management of NSCLC Pd-L1+ Patients in Italy
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
P2.04-05 Correlation Between PD-L1 Gene Promoter Polymorphisms and Expression of PD-L1 mRNA and Protein in NSCLC Patients.
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
MA09.09 EBUS-TBNA in Assessing PD-L1 Expression in NSCLC
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P073 CBL-B Predicts Prognosis of NSCLC Patients and Affects PD-L1 Expression in A549
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
45. A Retrospective Assessment of PD-L1 Expression Rates in NSCLC
Pathology
Forensic Medicine
Pathology
P1.01-08 Hyperresponsive Disease: A New Pattern of Response in NSCLC Patients Treated by Anti-Pd-1/Pd-L1
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
PD-L1-Hemmer Bei Vorbehandelten Patienten Mit NSCLC
Im Focus Onkologie
NSCLC: Zwei Positive Studien Zu PD-L1-Hemmer
Im Focus Onkologie
NSCLC: Atezolizumab Mit Überlebensvorteil Unabhängig Vom PD-L1-Status
Pneumologie
Medicine
Pulmonary
Respiratory Medicine
Pcp61 - Evidence-Based Value of Pd-1 / Pd-L1 Inhibitors in Nsclc: Comparison of Value to Price
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental